Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer.


Journal

Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 04 03 2020
revised: 28 05 2020
accepted: 06 06 2020
pubmed: 17 6 2020
medline: 15 12 2020
entrez: 16 6 2020
Statut: ppublish

Résumé

Many studies have reported a positive association between lower socioeconomic status (SES) and higher head and neck cancer (HNC) risk. Fewer studies have examined the impact of SES on the association between alcohol or cigarette use and HNC risk. The current case-control study (1104 HNC cases and 1363 controls) investigated the influence of education, a SES indicator, on the association between HNC and the use of alcohol, cigarettes, or betel quids in Taiwan, a country with universal health care. Our results showed a larger increase in HNC risk associated with alcohol among those with lower educational level (odds ratio [OR] = 2.07; 95% confidence interval [CI], 1.53-2.80) than those with higher educational level (OR = 1.38; 95% CI, 1.04-1.85) (heterogeneity-P = .03). Educational level had an influence on the association between alcohol use and HNC risk among those with genetic susceptibility (ALDH2-deficient) to the carcinogenic effect of alcohol. The association between cigarette or betel quid use and HNC risk was similar between the high and low educational groups. National policies and social interventions have led to the decline in the prevalence of cigarette and betel quid users in Taiwan. In contrast, due to the lack of adequate alcohol control policies, alcohol consumption in Taiwan has continued to rise. A higher impact of alcohol on HNC risk among lower SES individuals even with universal health care could be the result of insufficient alcohol control policies in Taiwan.

Identifiants

pubmed: 32539207
doi: 10.1111/cas.14530
pmc: PMC7419018
doi:

Substances chimiques

Calcium Compounds 0
Oxides 0
Plant Extracts 0
lime-piper betel quid 0
ALDH2 protein, human EC 1.2.1.3
Aldehyde Dehydrogenase, Mitochondrial EC 1.2.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2974-2986

Subventions

Organisme : Ministry of Science and Technology, Taiwan
ID : 107-2314-B-006-041-MY3
Organisme : National Health Research Institutes
ID : CA-109-PP-01
Organisme : Ministry of Science and Technology
Organisme : Health Research

Informations de copyright

© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Références

BMC Public Health. 2013 Sep 08;13:810
pubmed: 24010885
Alcohol Clin Exp Res. 2010 Nov;34(11):1961-71
pubmed: 20735372
Oral Oncol. 2015 Aug;51(8):727-30
pubmed: 26066977
Br J Cancer. 2010 Aug 24;103(5):741-6
pubmed: 20648009
Proc Natl Acad Sci U S A. 1984 Jan;81(1):258-61
pubmed: 6582480
Cancer Sci. 2020 Aug;111(8):2974-2986
pubmed: 32539207
Annu Rev Pharmacol Toxicol. 2015;55:107-27
pubmed: 25292432
Cancer. 2020 Mar 1;126(5):1031-1040
pubmed: 31814116
BMC Public Health. 2016 Jul 19;16:599
pubmed: 27430342
Eur J Cancer. 2010 Feb;46(3):588-98
pubmed: 19857956
London J Prim Care (Abingdon). 2010 Dec;3(2):115-9
pubmed: 25949636
Br J Cancer. 2007 May 7;96(9):1469-74
pubmed: 17387340
J Biomed Sci. 2017 Mar 3;24(1):19
pubmed: 28253921
Ann Oncol. 2012 Jul;23(7):1869-80
pubmed: 22123733
J Epidemiol Community Health. 2013 Feb;67(2):190-3
pubmed: 22875078
SSM Popul Health. 2018 Jun 08;5:129-137
pubmed: 30014030
Cancer Causes Control. 2018 Sep;29(9):863-873
pubmed: 30069657
Cancer Med. 2019 Feb;8(2):795-813
pubmed: 30609296
Ann Oncol. 2016 Aug;27(8):1619-25
pubmed: 27234641
Cancer. 2017 May 1;123(9):1597-1609
pubmed: 28055109
Saf Health Work. 2020 Mar;11(1):41-49
pubmed: 32206373
Ann Intern Med. 2008 Feb 19;148(4):258-67
pubmed: 18283203
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50
pubmed: 19190158
Int J Cancer. 2015 Mar 1;136(5):1125-39
pubmed: 24996155

Auteurs

Jenn-Ren Hsiao (JR)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Cheng-Chih Huang (CC)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Chun-Yen Ou (CY)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Chan-Chi Chang (CC)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Wei-Ting Lee (WT)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Sen-Tien Tsai (ST)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Jehn-Shyun Huang (JS)

Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Ken-Chung Chen (KC)

Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Yu-Hsuan Lai (YH)

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Yuan-Hua Wu (YH)

Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Wei-Ting Hsueh (WT)

Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Shang-Yin Wu (SY)

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Chia-Jui Yen (CJ)

Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Jang-Yang Chang (JY)

Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Chen-Lin Lin (CL)

Department of Nursing, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Ya-Ling Weng (YL)

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.

Han-Chien Yang (HC)

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.

Yu-Shan Chen (YS)

Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Jeffrey S Chang (JS)

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH